Reduction of heart volume during neoadjuvant chemoradiation in patients with resectable esophageal cancer

Radiotherapy and Oncology

Volumn 114, Issue 1, 2015, Pages 91-95

  Haj Mohammad, Nadia ^a   Kamphuis, Martijn ^a   Hulshof, Maarten C C M ^a   Lutkenhaus, Lotte J ^a   Gisbertz, Suzanne S ^a   Bergman, Jacques J G H M ^a   De Bruin Bon, H A C M Rianne ^a   Geijsen, Elisabeth D ^a   Bel, Arjan ^a   Boekholdt, S Mathijs ^a   Van Laarhoven, Hanneke W M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cardiac volume; Esophageal cancer; Neoadjuvant chemoradiation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CARBOPLATIN; CREATINE KINASE; CREATINE KINASE MB; CREATININE; PACLITAXEL; TROPONIN T; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CARDIAC VOLUME REDUCTION; CLINICAL ARTICLE; CONE BEAM COMPUTED TOMOGRAPHY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ESOPHAGUS CANCER; FEMALE; HEART DISEASE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART RATE; HEART VOLUME; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SYSTOLIC BLOOD PRESSURE; ADJUVANT THERAPY; BLOOD PRESSURE; DRUG EFFECTS; ESOPHAGEAL NEOPLASMS; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RADIATION DOSE; RADIATION RESPONSE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD PRESSURE; CARBOPLATIN; CARDIAC VOLUME; CHEMORADIOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PACLITAXEL; PROSPECTIVE STUDIES; RADIATION DOSAGE; RADIOTHERAPY DOSAGE;

EID: 84925047769     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.12.005     Document Type: Article

References (20)

1. J. Ferlay Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. Moore, A., Gastrointestinal cancer, in ASCO SEP, medical oncology, self evaluation program, A. Moore (Ed.), 2010, ASCO list. p. 101.
3. P. van Hagen Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
4. L.J. Lutkenhaus Reduction in cardiac volume during chemoradiotherapy for patients with esophageal cancer Radiother Oncol 109 2013 200 203
5. L. Gianni Anthracycline cardiotoxicity: from bench to bedside J Clin Oncol 26 2008 3777 3784
6. E.T. Yeh Cardiotoxicity induced by chemotherapy and antibody therapy Annu Rev Med 57 2006 485 498
7. M. Feng Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer Int J Radiat Oncol Biol Phys 79 2011 10 18
8. N.B. Schiller Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards. Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
9. R.M. Lang Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 18 2005 1440 1463
10. T.D. Crosby Definitive chemoradiation in patients with inoperable oesophageal carcinoma Br J Cancer 90 2004 70 75
11. A. Dolci Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use Am J Clin Pathol 130 2008 688 695
12. B. Ky Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab J Am Coll Cardiol 63 2014 809 816
13. M. Hatakenaka Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer: magnetic resonance evaluation Int J Radiat Oncol Biol Phys 83 2012 e67 e73
14. C. Kuropkat Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report Am J Clin Oncol 22 1999 466 470
15. T. Lieutaud 5-Fluorouracil cardiotoxicity: A unique mechanism for ischaemic cardiopathy and cardiac failure? Eur J Cancer 32A 1996 368 369
16. C. Schober Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer Cancer 72 1993 2242 2247
17. D.C. Doll Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis Ann Intern Med 105 1986 48 51
18. F. Icli Severe vascular toxicity associated with cisplatin-based chemotherapy Cancer 72 1993 587 593
19. M.T. Meinardi Cardiovascular morbidity in long-term survivors of metastatic testicular cancer J Clin Oncol 18 2000 1725 1732
20. L. Gianni Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study J Clin Oncol 13 1995 2688 2699